Herbal product contamination and toxicity

Journal of Pharmacy Practice

Volumn 18, Issue 3, 2005, Pages 188-208

  Smolinske, Susan C ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Adulteration; Herbal; Homeopathy; Poisoning; Toxicity

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ALKALOID; ALPRAZOLAM; AMILORIDE; AMITRIPTYLINE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ARSENIC; AYURVEDIC DRUG; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; CHLORPROMAZINE; CHLORPROPAMIDE; CHLORZOXAZONE; CISAPRIDE; CLOZAPINE; CORTICOSTEROID; CYCLOSPORIN; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; DECONGESTIVE AGENT; DEXTROMETHORPHAN; DIAZEPAM; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; EPHEDRA SINICA EXTRACT; EPHEDRINE; ESTAZOLAM; ESTROGEN; FELODIPINE; FENFLURAMINE; FEXOFENADINE; FLUMAZENIL; FLUPENTIXOL; FLUPHENAZINE; FLUVOXAMINE; FOLIC ACID; FUROSEMIDE; GLIBENCLAMIDE; GUANETHIDINE; HALOPERIDOL; HALOTHANE; HERBACEOUS AGENT; HYDROCHLOROTHIAZIDE; HYPNOTIC AGENT; HYPOPHYSIS HORMONE; IMIPRAMINE; IMMUNOSUPPRESSIVE AGENT; INDINAVIR; INSULIN; IRINOTECAN; KETOCONAZOLE; LAXATIVE; LEVOTHYROXINE; LITHIUM; LOOP DIURETIC AGENT; MANGANESE; MEFENAMIC ACID; MERCURY SULFIDE; METFORMIN; METHYLDOPA; MEVINOLIN; MIDAZOLAM; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NIFEDIPINE; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OLIVE OIL; OMEGA 3 FATTY ACID; OPIATE; ORAL ANTIDIABETIC AGENT; ORAL CONTRACEPTIVE AGENT; OXYTOCIN; PARACETAMOL; PC SPES; PENICILLIN G; PENICILLIN V POTASSIUM; PETHIDINE; PHENELZINE; PHENFORMIN; PHENOBARBITAL; PHENOTHIAZINE; PHENYTOIN; PHOSPHATIDYLSERINE; PLANT EXTRACT; PREDNISONE; PROCYCLIDINE; PROPAFENONE; PROPOFOL; PROPRANOLOL DERIVATIVE; QUINIDINE; SALBUTAMOL; SAQUINAVIR; SEDATIVE AGENT; SELEGILINE; SELENIUM; SEROTONIN UPTAKE INHIBITOR; SEVOFLURANE; SILDENAFIL; SIMVASTATIN; SPIRONOLACTONE; SUXAMETHONIUM; TAMOXIFEN; TETRACYCLINE; THEOPHYLLINE; THIAZIDE DIURETIC AGENT; THYROID HORMONE; TOLBUTAMIDE; TRAZODONE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; VITAMIN B GROUP; WARFARIN; ZIDOVUDINE;

ABDOMINAL PAIN; ACRODYNIA; ACUTE HEPATITIS; ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ALLERGIC VASCULITIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASTHMA; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BRADYKINESIA; BRONCHOSPASM; CARCINOGENICITY; CARDIOTOXICITY; CHILD RESISTANT CONTAINER; CHOLESTATIC HEPATITIS; CHOREA; COLLAPSE; COMA; CONTACT DERMATITIS; COUGHING; DEHYDRATION; DIARRHEA; DIET SUPPLEMENTATION; DRUG CONTAMINATION; DRUG IDENTIFICATION; DRUG INTOXICATION; DRUG LABELING; ECZEMA; ELECTROLYTE DISTURBANCE; ESOPHAGUS INJURY; FANCONI RENOTUBULAR SYNDROME; FIBROSING ALVEOLITIS; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; GRAFT REJECTION; GRANULOMATOUS HEPATITIS; HALLUCINATION; HEADACHE; HEALTH EDUCATION; HEART ARRHYTHMIA; HEART INFARCTION; HEART INJURY; HEART MUSCLE CONDUCTION DISTURBANCE; HEMOLYTIC ANEMIA; HERB DRUG INTERACTION; HOMEOPATHY; HUMAN; HYPERSENSITIVITY REACTION; HYPERTENSION; HYPOGLYCEMIA; HYPOKALEMIA; HYPOMANIA; HYPOTENSION; HYPOVOLEMIC SHOCK; INSOMNIA; INTERSTITIAL NEPHRITIS; IRRITABILITY; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TOXICITY; LIVER VENOOCCLUSIVE DISEASE; LUPUS ERYTHEMATOSUS; MEDICINAL PLANT; MENSTRUATION; MICROBIAL CONTAMINATION; MUSCLE WEAKNESS; MYOCARDITIS; NEPHROLITHIASIS; NEPHROTOXICITY; NEUROPATHY; PANCYTOPENIA; PATIENT EDUCATION; PHARMACIST; PHOTOTOXICITY; POISON CENTER; POSTOPERATIVE HEMORRHAGE; PURPURA; QT PROLONGATION; RECURRENT DISEASE; RETROBULBAR HEMORRHAGE; REVIEW; RHABDOMYOLYSIS; RIGIDITY; SEIZURE; SEROTONIN SYNDROME; SIDE EFFECT; STROKE; TACHYCARDIA; THROMBOCYTE AGGREGATION; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA; TONGUE DISEASE; TREMOR; UREMIA; URTICARIA; VAGINA BLEEDING; VOMITING;

EID: 18844413792     PISSN: 08971900     EISSN: None     Source Type: Journal    
DOI: 10.1177/0897190005277217     Document Type: Review

References (141)

1. Litovitz TL, Bailey KM, Schmitz BF, et al. 1990 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 1991;9:461-509.
2. Litovitz TL, Klein-Schwartz W, Dyer KS, Shannon M, Lee S, Powers M. 1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 1998;16:443-497.
3. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998;280:1569-1575.
4. Watson WA, Litovitz TL, Klein-Schwartz W, et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2004;22:335-404.
5. Palmer ME, Haller C, McKinney PE, et al. Adverse events associated with dietary supplements: an observational study. Lancet. 2003;361:101-106.
6. Moore C, Adler R. Herbal vitamins: lead toxicity and developmental delay. Pediatrics. 2000;106:600-602.
7. Mitchell-Heggs CAW, Conway M, Cassar J. Herbal medicine as a cause of combined lead and arsenic poisoning. Hum Exp Toxicol. 1990;9:195-196.
8. Ko RJ. Adulterants in Asian patent medicines. N Engl J Med. 1998;339:847.
9. De Krom MC, Boreas AM, Hardy EL. Manganese poisoning due to use of Chien Pu Wan tablets. Ned Tijdschr Geneeskd. 1994;138:2506.
10. Araujo J, Beelen AP, Lewis LD, et al. Lead poisoning associated with Ayurvedic medications: five states, 2000-2003. MMWR Morb Mortal Wkly Rep. 2004;53:582-584.
11. Super RB, Kales SN, Paquin J, et al. Heavy metal content of ayurvedic herbal medicine products. JAMA. 2004;292:2868-2873.
12. ConsumerLab.com Web site. Available at: www. consumerlabs.com.
13. Ross EA, Szabo NJ, Tebbett IR. Lead content of calcium supplements. JAMA. 2000;284:1425-1429.
14. Huang WF, Wen K-C, Hsiao M-L. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol. 1997;37:344-350.
15. Gertner E, Marshall PS, Filandrinos D, et al. Complications resulting from the use of Chinese herbal medications containing undeclared prescription drugs. Arthritis Rheum. 1995;38:614-617.
16. Kanda T, Yokosuka O, Tada M, et al. N-nitroso-fenfluramine hepatotoxicity resembling chronic hepatitis. J Gastroenterol Hepatol. 2003;18:999-1000.
17. Montoya-Cabrera MA, Rubio-Rodriguez S, Velazquez-Gonzalez E, Avila-Montoya S. Mercury poisoning caused by a homeopathic drug [in Spanish]. Gac Med Mex. 1991;127:267-270.
18. Audicana M, Bernedo N, Gonzalez I, et al. An unusual case of baboon syndrome due to mercury present in a homeopathic medicine. Contact Dermatitis. 2001;45:185.
19. Stevens WJ. Thallium intoxication caused by a homoeopathic preparation. Toxicologie Clinique. 1978;1:317-320.
20. Chakraborti D, Mukherjee SC, Saha KC, et al. Arsenic toxicity from homeopathic treatment. J Toxicol Clin Toxicol. 2003;41:963-967.
21. Kerr HD, Saryan LA. Arsenic content of homeopathic medicines. J Toxicol Clin Toxicol. 1986;24:451-459.
22. Gupta SK, Kaleekal T, Joshi S. Misuse of corticosteroids in some of the drugs dispensed as preparations from alternative systems of medicine in India. Pharmacoepidemiol Drug Saf. 2000;9:599-602.
23. Roy AK, Sinha KK, Chourasia HK. Aflatoxin contamination of some common drug plants. Appl Environ Microbiol. 1988;54:842-843.
24. Food and Drug Administration. Foodborne pathogenic microorganisms and natural toxins handbook: aflatoxins. Available at: http://vm.cfsan.fda.gov/~mow/ chap41.html.
25. Miller L, Mangione E, Beeba J, et al. Infection with Mycobacterium abscessus associated with intramuscular injection of adrenal cortex extract - Colorado and Wyoming, 1995-1996. MMWR Morb Mortal Wkly Rep. 1996;45:713-714.
26. Food and Drug Administration. Caution with Kombucha. FDA Consumer. 1995;June:4-5.
27. Mayser P, Fromme S, Leitzmann C, et al. The yeast spectrum of the "tea fungus Kombuch." Mycoses. 1995;38:289-295.
28. Sadjadi J. Cutaneous anthrax associated with Kombuch mushroom in Iran. JAMA. 1998;280:1567-1568.
29. Srinivasan R, Smolinske S, Greenbaum D. Probable gastrointestinal toxicity of Kombucha tea. J Gen Intern Med. 1997;12:643-644.
30. Perron AD, Patterson JA, Yanofsky NN. Kombucha mushroom hepatotoxicity. Ann Emerg Med. 1995;26:660-661.
31. Currier RW, Goddard J, Buechler K, et al. Unexplained severe illness possibly associated with consumption of Kombucha tea: Iowa, 1995. MMWR Morb Mortal Wkly Rep. 1995;44:892-900.
32. Holmer A, Govan J, Goldstein R. Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis. 1998;4:221-227.
33. Food and Drug Administration. Solgar vitamin and herb company recalls solgar's digestive aid 100's dietary supplements because of possible salmonella contamination. FDA Talk Paper. April 27, 2001.
34. Nakashima MJ, Angold S, Beavin BB, et al. Extraction of light filth from spirulina powders and tablets: collaborative study. J Assoc Off Anal Chem. 1989;72:451-453.
35. Food and Drug Administration. FDA initiates seizure of ginseng because of potentially risky pesticide residues. FDA Talk Paper. December 16, 2004.
36. Johnson PE, Shubert LE. Accumulation of mercury and other elements by spirulina (cyanophyceae). Nutr Rep Int. 1986;34:1063-1071.
37. Food Safety Authority of Ireland. Summary of investigation of dioxins, furans and PCBs in farmed salmon, wild salmon, farmed trout and fish oil capsules, March 2002. Available at: http://www.fsai.ie/surveillance/food/ surveillance_food_summarydioxins.asp.
38. Food Standards Agency. Dioxin levels down, fish oil supplement survey finds. June 21, 2002. Available at: http://www.food.gov.uk/news/newsarchive/ 2002/jun/fishsupplement.
39. ConsumerLab.com. Product review. Omega-3 fatty acids (EPA and DHA) from fish/marine oils. Available at: http://consumerlab.com/results/omega3.asp.
40. De Smet PAGM, Elfbrink F, Verpoorte R. Linksdraaiend tetrahydropalmitine in Chinese tablet. Ned Tijdschr Geneeskd. 1989;133:308.
41. Horowitz RS, Dart RC, Gomez H, et al. Jin Bu Huan toxicity in children: Colorado, 1993. MMWR Morb Mortal Wkly Rep. 1993;42:633-634.
42. Woolf GM, Rojtar SE, Villamil FG, et al. Jin Bu Huan toxicity in adults: Los Angeles, 1993. MMWR Morb Mortal Wkly Rep. 1993;42:920-922.
43. But PP-H. Herbal poisoning caused by adulterants or erroneous substitutes. J Trop Med Hyg. 1994;97:371-374.
44. Slifman NR, Obermeyer WR, Aloi BK, et al. Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med. 1988;399:806-811.
45. Food and Drug Administration. FDA warns against dietary supplement product, "Chomper." FDA Medical Bulletin. 1997;27(2). Available at: http://www.fda.gov/medbull/fdawarns.html.
46. Barrueto F, Jortani SA, Valdes R, et al. Cardioactive steroid poisoning from an herbal cleansing preparation. Ann Emerg Med. 2003;41:396-399.
47. Frasca T, Brett AS, Yoo SD. Mandrake toxicity: a case of mistaken identity. Arch Intern Med. 1997;157:2007-2009.
48. Mayer D, Forstner K. Impact of dehydroepiandrosterone on hepatocarcinogenesis in the rat. Int J Oncol. 2004;25:1021-1030.
49. Helzlsouer KJ, Alberg AJ, Gordon GB, et al. Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA. 1995;274:1926-1930.
50. Harkey MR, et al. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr. 2001;73:1101-1106.
51. Draves AH, Walker SE. Analysis of the hypericin and pseudohypericini content of commercially available St John's wort preparations. Can J Clin Pharmacol. 2003;10:114-118.
52. Coppes MJ, Anderson RA, Egeler RM, Wolff JE. Alternative therapies for the treatment of childhood cancer. N Engl J Med. 1998;339:846-847.
53. Jochmisen EM, Carmichael WW, An JS, et al. Liver failure and death after exposure to microcystins at a hemodialysis center in Brazil. N Engl J Med. 1998;338:873-878.
54. Mullins RJ, Heddle R. Adverse reactions associated with echinacea: the Australian experience. Ann Allergy Asthma Immunol. 2002;88:42-51.
55. Soon SL, Crawford RI. Recurrent erythema nodosum associated with echinacea herbal therapy. J Am Acad Dermatol. 2001;44:298-299.
56. Cardinali C, Francalanci S, Giomi B, et al. Contact dermatitis from Rhus toxicodendron in a homeopathic remedy. J Am Acad Dermatol. 2004;50:150-151.
57. Monk B. Severe cutaneous reactions to alternative remedies. Br Med J. 1986;293:665-666.
58. Aberer W, Strohal R. Homeopathic preparations: severe adverse effects, unproven benefits. Dermatologica. 1991;182:253.
59. Helbling A, Brander KA, Pichler WJ. Anaphylactic shock after subcutaneous injection of mandragore D3, a homeopathic drug. J Allergy Clin Immunol. 2000;106:989-990.
60. Davydov L, Stirling AL. Stevens-Johnson syndrome with Ginkgo biloba. J Herb Pharmacother. 2001;1:65-68.
61. Bove GM. Acute neuropathy after exposure to sun in a patient treated with St John's wort. Lancet. 1998;352:1121-1122.
62. Estes JD, Stolpman D, Olyaei A, et al. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg. 2003;138:852-858.
63. Hamid S, Rojter S, Vierling J. Protracted cholestatic hepatitis after the use of Prostata. Ann Intern Med. 1997;127:169-170.
64. Shad JA, Chinn CG, Brann OS. Acute hepatitis after ingestion of herbs. South Med J. 1999;92:1095-1097.
65. Lontos S, Jones RM, Angus PW, Gow PJ. Acute liver failure associated with the use of herbal preparations containing black cohosh. Med J Aust. 2003;179:390-391.
66. O'Connor AM, Merel NH, Te HS, Cohen SM. A case of autoimmune hepatitis associated with the use of black cohosh [abstract]. Am J Gastroenterol. 2003;98:165.
67. Vitetta L, Thomsen M, Sali A. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust. 2003;178:411-412.
68. Sheikh NM, Philen RM, Love LA. Chaparral-associated hepatotoxicity. Arch Intern Med. 1997;157:913-919.
69. Lanca S, Alves A, Vieira AI, et al. Chromium-induced toxic hepatitis. Eur J Intern Med. 2002;13:518-520.
70. Haller CA, Dyer JE, Ko R, et al. Making a diagnosis of herbal related hepatitis. West J Med. 2002;176:39-44.
71. Larrey D, Vial T, Pauwels A, et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med. 1992;117:129-132.
72. Halner MI, Tsai N, Komura ST, et al. Fatal hepatorenal failure associated with hydrazine sulfate. Ann Intern Med. 2000;133:877-890.
73. The Review of Natural Products by Facts and Comparisons. St Louis, Mo: Wolters Kluwer; 1999.
74. Bah M, Bye R, Pereda-Miranda R. Hepatotoxic pyrrolizidine alkaloids in the Mexican medicinal plant Packera candidissima. J Ethnopharmacol. 1994;43:19-30.
75. Anderson IB, Mullen WH, Meeker JE, et al. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med. 1996;124:726-734.
76. Bakerink JA, Gospe SM Jr, Dimand RJ, et al. Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Pediatrics. 1996;98:944-947.
77. MacGregor FB, Abernethy VE, Dahabra S, et al. Hepatotoxicity of herbal remedies. Br Med J. 1989;299:1156.
78. Hullar TE, Sapers BL, Ridker PM, et al. Herbal toxicity and fatal hepatic failure. Am J Med. 1999;106:267-268.
79. Ashar B, Vargo E. Shark cartilage-induced hepatitis [letter]. Ann Intern Med. 1996;125:780-781.
80. Nortier JL, Martinez MC, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med. 2000;342:1686-1692.
81. van Ypersele de Strihou C, Vanherweghem JL. The tragic paradigm of Chinese herbs nephropathy. Nephrol Dial Transplant. 1995;10:157-160.
82. Vanherweghem J-L, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet. 1993;341:387-391.
83. Baillie N, Rasmussen P. Black and blue cohosh in labour. N Z Med J. 1997;110:20-21.
84. Hilepo JN, Bellucci AG, Mossey RT. Acute renal failure caused by "cat's claw" herbal remedy in a patient with systemic lupus erythematosus [letter]. "Nephron. 1997;77:361-369.
85. Cerulli J, Grabe DW, Gauthier I, et al. Chromium picolinate toxicity. Ann Pharmacother. 1998;32:428-431.
86. Wasser WG, Feldman NS, D'Agati VD. Chronic renal failure after ingestion of over-the-counter chromium picolinate [letter]. Ann Intern Med. 1997;126:410.
87. Matsusaka T, Fujii M, Nakano T, et al. Germanium-induced nephropathy: report of two cases and review of the literature. Clin Nephrol. 1988;30:341-345.
88. Hess B, Raisin J, Zimmermann A, et al. Tubulointerstitial nephropathy persisting 20 months after discontinuation of chronic intake of germanium lactate citrate. Am J Kidney Dis. 1993;21:548-552.
89. Takeuchi A, Yoshizawa N, Oshima S, et al. Nephrotoxicity of germanium compounds: report of a case and review of the literature. Nephron. 1992;60:436-442.
90. Hellberg K, Ruschewski W, de Vivie R. Medikamentoes bedingtes post-operatives Nierenversagen nach herzchirurgischen Eingriffen. Vask Chir. 1975;23:396-399.
91. Powell T, Hsu FF, Turk J, Hruska K. Ma-huang strikes again: ephedrine nephrolithiasis. Am J Kidney Dis. 1998;32:153-159.
92. Chang JM, Hwang SJ, Kuo HT, et al. Fatal outcome after ingestion of star fruit (Averhhoa carambola) in uremic patients. Am J Kidney Dis. 2000;35:189-193.
93. Weisbord SD, Soule JB, Kimmel PL. Poison on line: acute renal failure caused by oil of wormwood purchased through the Internet. N Engl J Med. 1997;337:825-827.
94. Gregory PJ. Seizure associated with Ginkgo biloba? Ann Intern Med. 2001;134:344.
95. Granger AS. Ginkgo biloba precipitating epileptic seizures. Age Aging. 2001;30:523-525.
96. Kajiyama Y, Fujii K, Mizuno Y. Ginkgo seed poisoning. Pediatrics. 2002;109:325.
97. Miwa H, Iijima M, Tanaka S, et al. Generalized convulsions after consuming a large amount of ginkgo nuts. Epilepsia. 2001;42:280-281.
98. Newall CA, Anderson LA, Philpson JD. Herbal Medicine: A Guide for Healthcare Professionals. London, UK: Pharmaceutical Press; 1996.
99. Barber AJ. Evening primrose oil: a panacea? Pharm J. 1998;June 4:723-725.
100. FDA issue advisory on star anise "teas." FDA News. P03-67. September 10, 2003.
101. Ize-Ludlow D, Ragone S, Bernstein JN, et al. Chemical composition of Chinese star anise (Illicium verum) and neurotoxicity in infants. JAMA. 2004;291:562-563.
102. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343:1833-1838.
103. Morgenstern LB, Viscoli CM, Kernan WN, et al. Use of ephedra-containing products and risk for hemorrhagic stroke. Neurology. 2003;60:132-135.
104. Nykamp DL, Fackih MN, Compton AL. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement. Ann Pharmacother. 2004;38:812-816.
105. Calapai G, Firenzuoli F, Saiita A, et al. Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat: a preliminary report. Fitoterapia. 1999;70:586-592.
106. Siegel RK. Ginseng abuse syndrome: problems with the panacea. JAMA. 1979;241:1614-1615.
107. But PP, Tai YT, Young K. Three fatal cases of herbal aconite poisoning. Vet Hum Toxicol. 1994;36:212-215.
108. Fisher AA, Purcell P, Le Couteur DG. Toxicity of Passiflora incarnata L. J Toxicol Clin Toxicol. 2000;38:63-66.
109. Chou WC, Wu CC, Yang PC. Hypovolemic shock and mortality after Ingestion of Tripterygium wilfordii hook F: a case report. Int J Cardiol. 1995;49:173-177.
110. Lacomblez L, Bensimon G, Isnard F, et al. Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine. Clin Pharmacol Ther. 1989;45:241-251.
111. Kurtzwell P. Dieter's brews make tea time a dangerous affair. FDA Consumer. July-August 1997:6-10.
112. Adverse Drug Reactions Advisory Committee. An adverse reaction to the herbal medication milk thistle (Silybum marianum). Med J Aust. 1999;170:218-219.
113. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion [letter]. Neurology. 1996;46:1775-1776.
114. Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet. 1998;352:36.
115. Benjamin J, Muir T, Briggs K, et al. A case of cerebral haemorrhage: can Ginkgo biloba be implicated? Postgrad Med J. 2001;77(904):112-113.
116. Gilbert GJ. Ginkgo biloba [letter]. Neurology. 1997;48:1137.
117. Norred CL, Finlayson CA. Hemorrhage after the preoperative use of complementary and alternative medicines. AANA J. 2000;68:217-220.
118. Fessenden JM, Wittenborn W, Clarke L. Ginkgo biloba: a case report of herbal medicine and bleeding postoperatively from a laparoscopic cholescystectomy. Am Surg. 2001;67:33-35.
119. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract [letter]. N Engl J Med. 1997;336:1108.
120. Hauser D, Gayowski T, Singh N. Bleeding complications precipitated by unrecognized Ginkgo biloba use after liver transplantation. Transpl Int. 2002;15:377-379.
121. Malinow MR, Bardana EJ Jr, Goodnight SH Jr. Pancytopenia during ingestion of alfalfa seeds. Lancet. 1981;4:615.
122. Schroder H, Losche W, Strobach H, et al. Helenalin and 11 alpha, 13-dihydrohelenalin, two constituents from Arnica montana L., inhibit human platelet function via thiol-dependent pathways. Thromb Res. 1990;57:839-845.
123. Lambert J, Cormier J. Potential interaction between warfarin and boldo-fenugreek. Pharmacotherapy. 2001;21:509-512.
124. Taussig SJ, Batkin S. Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application: an update. J Ethnopharmacol. 1988;22:191-203.
125. Hogaboam CM, Wallace JL. Inhibition of platelet aggregation by capsaicin: an effect unrelated to actions on sensory afferent neurons. Eur J Pharmacol. 1991;202:129-131.
126. Cerulli J, Grabe DW, Gauthier I, et al. Chromium picolinate toxicity. Ann Pharmacother. 1998;32:428-431.
127. Wang N, Luo HW, Niwa M, Ji J. A new platelet aggregation inhibitor from Salvia miltiorrhiza. Planta Med. 1989;55:390-391.
128. Chan TY. Interaction between warfarin and danshen (Salvia miltiorrhiza). Ann Pharmacother. 2001;35:501-504.
129. Biggs MJ, Johnson ES, Persaud NP, Ratcliffe DM. Platelet aggregation in patients using feverfew for migraine. Lancet. 1982;2:776.
130. Food and Drug Administration. Center for Food Safety and Applied Nutrition. Letter regarding dietary supplement health claim for omega-3 fatty acids and coronary heart disease. Available at: http://vm.cfsan.fda.gov/~dms/ds- ltr11.html.
131. Pedersen HS, Mulvad G, Seidelin KN, et al. N-3 fatty acids as a risk factor for haemorrhagic stroke. Lancet. 1999;353:812-813.
132. Carden SM, Good WV, Carden PA, Good RM. Garlic and the strabismus surgeon. Clin Experiment Ophthalmol. 2002;30:303-304.
133. Burnham BE. Garlic as a possible risk for postoperative bleeding. Plast Reconstr Surg. 1995;95:213.
134. Rose KD, Croissant PD, Parliament CF, Levin MB. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery. 1990;26:880-882.
135. Hopkins MP, Androff L, Benninghoff AS. Ginseng face cream and unexplained vaginal bleeding. Am J Obstet Gynecol. 1988;159:1121-1122.
136. Greenspan EM. Ginseng and vaginal bleeding. JAMA. 1983;249:2018.
137. Yue QY, Bergquist C, Gerden B. Safety of St John's wort (Hypericum perforatum). Lancet. 2000;355:576-577.
138. Mai I, Bauer S, Perloff ES, et al. Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction. Clin Pharmacol Ther. 2004;76:330-340.
139. Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Health-Syst Pharm. 1997;54:692-693.
140. Rosasdo MF. Thrombosis of a prosthetic aortic valve disclosing a hazardous interaction between warfarin and a commercial ginseng product. Cardiology. 2003;99:111.
141. Yuan CS, Wei G, Dey L, et al. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial. Ann Intern Med. 2004;141:23-27.